Literature DB >> 1486499

Effects of peripheral nerve injuries and tissue inflammation on the levels of neuropeptide Y-like immunoreactivity in rat primary afferent neurons.

S Wakisaka1, K C Kajander, G J Bennett.   

Abstract

Changes in neuropeptide Y-like immunoreactivity (NPYir) in the rat L4 and L5 spinal cord and dorsal root ganglia (DRG) were examined after different sciatic nerve injuries (transection, loose ligation, and crush) and a localized, painful inflammation of the hind paw. Inflammation had no effect on NPYir. All the nerve injuries produced comparable increases in NPYir in ipsilateral laminae III-V axons and varicosities, and induction of NPYir in many DRG cells. Most NPYir DRG cells were medium to large (mean diameters: 40-45 microns); less than 2% of the cells had diameters of 25 microns or less. We conclude that the nerve injury-evoked increase in NPYir occurs mostly in the somata and intraspinal arbors of low-threshold mechanoreceptors; very few, if any, C-fiber afferents are involved. Nerve injury, rather than a painful condition, appears to be the stimulus for the induction of NPYir synthesis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1486499     DOI: 10.1016/0006-8993(92)90206-o

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  28 in total

1.  Tonic inhibition of chronic pain by neuropeptide Y.

Authors:  Brian Solway; Soma C Bose; Gregory Corder; Renee R Donahue; Bradley K Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-11       Impact factor: 11.205

2.  Neuropeptide Y modulates effects of bradykinin and prostaglandin E2 on trigeminal nociceptors via activation of the Y1 and Y2 receptors.

Authors:  J L Gibbs; A Diogenes; K M Hargreaves
Journal:  Br J Pharmacol       Date:  2006-12-04       Impact factor: 8.739

3.  Neuropeptide Y release in the rat spinal cord measured with Y1 receptor internalization is increased after nerve injury.

Authors:  Juan Carlos Marvizon; Wenling Chen; Weisi Fu; Bradley K Taylor
Journal:  Neuropharmacology       Date:  2019-08-02       Impact factor: 5.250

4.  Inflammation and nerve injury induce expression of pancreatitis-associated protein-II in primary sensory neurons.

Authors:  Shao-Qiu He; Jun-Ru Yao; Fang-Xiong Zhang; Qiong Wang; Lan Bao; Xu Zhang
Journal:  Mol Pain       Date:  2010-04-26       Impact factor: 3.395

5.  Topography and time course of changes in spinal neuropeptide Y immunoreactivity after spared nerve injury.

Authors:  A B Intondi; J E Zadina; X Zhang; B K Taylor
Journal:  Neuroscience       Date:  2009-10-30       Impact factor: 3.590

6.  Neuropeptide Y inhibits capsaicin-sensitive nociceptors via a Y1-receptor-mediated mechanism.

Authors:  J Gibbs; C M Flores; K M Hargreaves
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

7.  Cutaneous tissue damage induces long-lasting nociceptive sensitization and regulation of cellular stress- and nerve injury-associated genes in sensory neurons.

Authors:  Kristofer K Rau; Caitlin E Hill; Benjamin J Harrison; Gayathri Venkat; Heidi M Koenig; Sarah B Cook; Alexander G Rabchevsky; Bradley K Taylor; Tsonwin Hai; Jeffrey C Petruska
Journal:  Exp Neurol       Date:  2016-06-03       Impact factor: 5.330

8.  Neuropeptide Y tonically inhibits an NMDAR➔AC1➔TRPA1/TRPV1 mechanism of the affective dimension of chronic neuropathic pain.

Authors:  Weisi Fu; Caitlin R Wessel; Bradley K Taylor
Journal:  Neuropeptides       Date:  2020-01-24       Impact factor: 3.286

9.  Neuropeptide Y inhibits axonal transport of particles in neurites of cultured adult mouse dorsal root ganglion cells.

Authors:  Hiromi Hiruma; Ayako Saito; Tatsumi Kusakabe; Toshifumi Takenaka; Tadashi Kawakami
Journal:  J Physiol       Date:  2002-08-15       Impact factor: 5.182

10.  Y1 receptor knockout increases nociception and prevents the anti-allodynic actions of NPY.

Authors:  K E Kuphal; B Solway; T Pedrazzini; B K Taylor
Journal:  Nutrition       Date:  2008-09       Impact factor: 4.008

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.